JP2008515897A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008515897A5 JP2008515897A5 JP2007535753A JP2007535753A JP2008515897A5 JP 2008515897 A5 JP2008515897 A5 JP 2008515897A5 JP 2007535753 A JP2007535753 A JP 2007535753A JP 2007535753 A JP2007535753 A JP 2007535753A JP 2008515897 A5 JP2008515897 A5 JP 2008515897A5
- Authority
- JP
- Japan
- Prior art keywords
- dimethyl
- compound
- methyl
- oxo
- morpholin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*C(*)(*)c(cc1)ccc1C1=P*=I*=B1 Chemical compound C*C(*)(*)c(cc1)ccc1C1=P*=I*=B1 0.000 description 2
- KYWXRBNOYGGPIZ-UHFFFAOYSA-N CC(N1CCOCC1)=O Chemical compound CC(N1CCOCC1)=O KYWXRBNOYGGPIZ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61602404P | 2004-10-05 | 2004-10-05 | |
| US11/242,318 US7671052B2 (en) | 2004-10-05 | 2005-10-03 | Phenyl derivatives and methods of use |
| PCT/US2005/035677 WO2006041841A1 (en) | 2004-10-05 | 2005-10-04 | Phenyl derivatives and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008515897A JP2008515897A (ja) | 2008-05-15 |
| JP2008515897A5 true JP2008515897A5 (https=) | 2009-02-05 |
Family
ID=36126358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007535753A Pending JP2008515897A (ja) | 2004-10-05 | 2005-10-04 | フェニル誘導体及びそれを使用する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7671052B2 (https=) |
| EP (1) | EP1817277A4 (https=) |
| JP (1) | JP2008515897A (https=) |
| CN (1) | CN101035758B (https=) |
| AU (1) | AU2005294459A1 (https=) |
| BR (1) | BRPI0516544A (https=) |
| CA (1) | CA2583297A1 (https=) |
| MX (1) | MX2007003826A (https=) |
| WO (1) | WO2006041841A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0427954D0 (en) * | 2004-12-21 | 2005-01-26 | Univ London | Modulator |
| CA2654026A1 (en) * | 2006-06-08 | 2007-12-13 | Neurokey A/S | Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
| WO2008109027A2 (en) * | 2007-03-02 | 2008-09-12 | University Of Tennessee Research Foundation, The | Tri-aryl/heteroaroaromatic cannabinoids and use thereof |
| CN101815513B (zh) * | 2007-08-07 | 2012-11-14 | 斯泰伦博斯大学 | 含有对乙酰氨基苯酚的眼用制剂 |
| EP2211619A1 (en) * | 2007-10-18 | 2010-08-04 | Merck Sharp & Dohme Corp. | Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| WO2009140078A1 (en) * | 2008-05-16 | 2009-11-19 | The Procter & Gamble Company | Treatment of lower urinary tract dysfunction with cb2-receptor-selective agonists |
| KR20110130489A (ko) * | 2009-03-23 | 2011-12-05 | 스미또모 가가꾸 가부시끼가이샤 | 시클로프로판카르복실산에스테르의 제조 방법 |
| US9855225B2 (en) * | 2011-08-18 | 2018-01-02 | Temple University Office Of Technology Transfer | Cannabinoid receptor treatments |
| CN103288684B (zh) * | 2013-05-03 | 2014-12-10 | 西安交通大学 | 一种具有抗肿瘤活性的联苯脲化合物及其制备方法 |
| US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
| US12364668B2 (en) | 2017-11-15 | 2025-07-22 | The Regents Of The University Of California | Treatment of opioid use disorder, opioid withdrawal symptoms, and chronic pain |
| US12409131B2 (en) | 2019-10-03 | 2025-09-09 | Pike Therapeutics Usa, Inc. | Transdermal delivery of dronabinol |
| CN114650809A (zh) | 2019-10-03 | 2022-06-21 | 斯塔顿治疗公司 | 屈大麻酚的透皮递送 |
| CA3155176A1 (en) | 2019-10-11 | 2021-04-15 | Pike Therapeutics, Inc., 1219014 B.C. Ltd. | Transdermal compositions comprising cannabidiol (cbd) for use in the treatment of seizure disorders |
| US12016829B2 (en) | 2019-10-11 | 2024-06-25 | Pike Therapeutics Inc. | Pharmaceutical composition and method for treating seizure disorders |
| CA3155181A1 (en) | 2019-10-14 | 2021-04-22 | Pike Therapeutics, Inc., 1219014 B.C. Ltd. | Transdermal delivery of cannabidiol |
| US12268699B2 (en) | 2019-10-14 | 2025-04-08 | Pike Therapeutics Inc. | Transdermal delivery of tetrahydrocannabinol |
| US12121617B2 (en) | 2019-10-14 | 2024-10-22 | Pike Therapeutics Inc. | Transdermal delivery of cannabidiol |
| EP3838967A1 (en) * | 2019-12-16 | 2021-06-23 | Spago Nanomedical AB | Immobilization of phenolic compounds |
| JP7687721B2 (ja) * | 2020-12-25 | 2025-06-03 | エムティックスバイオ カンパニ－ リミテッド | 新規なアミノアルカン酸にビフェニル基を導入した誘導体化合物およびそれを含む抗炎症用組成物 |
| EP4276092A4 (en) * | 2021-01-06 | 2025-01-01 | Chugai Seiyaku Kabushiki Kaisha | Compound library |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3663608A (en) * | 1969-12-10 | 1972-05-16 | Bristol Myers Co | 1-phenyl-3-aminoalkyl-1,2,3,4-tetrahydronaphthalenes and the salts thereof |
| US4055664A (en) * | 1975-02-10 | 1977-10-25 | Armour Pharmaceutical Company | Pharmaceutical preparations containing 4-(4-biphenylyl) butylamines and treatment of the animal organism therewith |
| DE3063585D1 (en) | 1979-05-19 | 1983-07-07 | Beecham Group Plc | Chroman derivatives, processes for their preparation and pharmaceutical compositions containing them |
| JP2002363164A (ja) * | 2001-04-06 | 2002-12-18 | Mitsubishi Chemicals Corp | ピラゾールカルボキサミド類、その中間体およびこれを有効成分とする有害生物防除剤 |
| WO2003091189A1 (en) * | 2002-04-25 | 2003-11-06 | Virginia Commonwealth University | Cannabinoids |
| US20040087590A1 (en) * | 2002-08-23 | 2004-05-06 | University Of Connecticut | Novel biphenyl and biphenyl-like cannabinoids |
| ATE455096T1 (de) * | 2002-11-19 | 2010-01-15 | Galderma Res & Dev | Biaromatische verbindungen die ppar-gamma rezeptoren aktivieren und deren anwendungen in kosmetischen oder pharmazeutischen zusammensetzungen |
| WO2004052846A1 (en) * | 2002-12-06 | 2004-06-24 | Bayer Healthcare Ag | Tetrahydro-naphthalene derivatives |
| SE0300010D0 (sv) | 2003-01-07 | 2003-01-07 | Astrazeneca Ab | Novel Compounds |
-
2005
- 2005-10-03 US US11/242,318 patent/US7671052B2/en not_active Expired - Fee Related
- 2005-10-04 WO PCT/US2005/035677 patent/WO2006041841A1/en not_active Ceased
- 2005-10-04 JP JP2007535753A patent/JP2008515897A/ja active Pending
- 2005-10-04 MX MX2007003826A patent/MX2007003826A/es not_active Application Discontinuation
- 2005-10-04 BR BRPI0516544-0A patent/BRPI0516544A/pt not_active IP Right Cessation
- 2005-10-04 CA CA002583297A patent/CA2583297A1/en not_active Abandoned
- 2005-10-04 AU AU2005294459A patent/AU2005294459A1/en not_active Abandoned
- 2005-10-04 CN CN2005800340695A patent/CN101035758B/zh not_active Expired - Fee Related
- 2005-10-04 EP EP05810259A patent/EP1817277A4/en not_active Withdrawn
-
2010
- 2010-01-18 US US12/689,078 patent/US20100168108A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008515897A5 (https=) | ||
| US7528170B2 (en) | Sulfonamide derivatives for the treatment of diseases | |
| ES2298757T3 (es) | Derivados de z-amino-piridina como agonistas de adrecorreceptores beta-2. | |
| ES2289691T3 (es) | Derivados de sulfonamida para el tratamiento de enfermedades. | |
| NZ582056A (en) | Bicyclic heteroaryl compounds for treating conditions related to p2x7 receptor activation | |
| JP2009505962A5 (https=) | ||
| JP2005509024A5 (https=) | ||
| EP1611097A1 (en) | Indole derivatives useful for the treatment of deseases | |
| MXPA06002551A (es) | Compuestos de aril o heteroaril amida. | |
| HRP20100418T1 (hr) | Novi spojevi aminobenzofenona | |
| JP2006503019A5 (https=) | ||
| KR20050083563A (ko) | 카나비노이드-1 수용체에서 활성인 치환된 아미드 | |
| KR100749990B1 (ko) | 베타2 효능제로서의(2-히드록시-2-(4-히드록시-3-히드록시메틸페닐)-에틸아미노)-프로필 페닐 유도체 | |
| KR20150061647A (ko) | 치환된 설폰아미드 화합물 | |
| KR20080083352A (ko) | 안트라닐아미드/2-아미노-헤테로아렌 카복스아미드 유도체 | |
| US7482487B2 (en) | Phenylaminoethanol derivatives as β2 receptor agonists | |
| JP2006508987A5 (https=) | ||
| WO2005092841A1 (en) | Compounds having beta-agonist activity | |
| JP2003528856A (ja) | ナフタレン誘導体およびその医薬的使用 | |
| WO2006051373A1 (en) | Compounds for the treatment of diseases | |
| JP2002521360A (ja) | Ｎ−ベンゾシクロアルキルアミド誘導体およびその医薬としての使用 | |
| AU2005225638A1 (en) | Compounds for the treatment of diseases | |
| JP4054366B2 (ja) | 疾患の治療のために有用な化合物 | |
| JP2004530650A5 (https=) | ||
| CN108602775B (zh) | 肥大细胞调节剂及其用途 |